A comprehensive view of European Lung Cancer Congress (ELCC). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

J&J to present new data from the Phase 3 MARIPOSA and Phase 1b PALOMA studies on RYBREVANT-based lung cancer treatments at the European Lung Cancer Congress; the studies aim to improve standard of care in EGFR-mutated non-small cell lung cancer
Published: March 18, 2024 by Janssen Pharmaceutical Companies

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count